Borgstein PJ, Meijer S, Pijpers RJ, van Diest PJ: Functional Lymphatic Anatomy for Sentinel Node Biopsy in Breast Cancer. Annals of Surgery, 2000, 232(1):81-89.
Carlo JT, Grant MD, Knox SM, Jones RC, Hamilton CS, Livingston SA, Kuhn JA: Survival analysis following sentinel lymph node biopsy: a validation trial demonstrating its accuracy in staging early breast cancer. BUMC Proceedings, 2005, 18:103-107.
Cody HS, Fey J, Akhurst T, Fazzari M, Mazumdar M, Yeung H, Yeh SDJ, Borgen PI: Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures. Annals of Surgical Oncology, 2001, 8(1):13-19.
Cody,III HS: Clinical aspects of sentinel node biopsy. Breast Cancer Research, 2001, 3:104-108.
Ganaraj A, Kuhn JA, Jones RC, Grant MD, Andrews VR, Knox SM, Netto GJ, Altrabulsi B, Livingston SA, McCarty TM: Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node. BUM Proceedings, 2003, 16:3-6.
Hill ADK, Tran KN, Akhurst T, Yeung H, Yeh SDJ, Rosen PP, Borgen PI, Cody,III HS: Lessons Learned from 500 Cases of Lymphatic Mapping for Breast Cancer. Annals of Surgery, 1999, 229(4):528-535.
Jeruss JS, Winchester DJ, Sener SF, Brinkmann EM, Bilimoria MM, Berrera, Jr. E, Alwawi E, Nickolov A, Schermerhorn GM, Winchester DJ: Axillary Recurrence After Sentinel Node Biopsy. Annals of Surgical Oncology, 2005, 12(1):34-40.
King TA, Fey JV, Van Zee KJ, Heerdt AS, Gemignani ML, Port ER, Sclafani L, Sacchini V, Petrek JA, Cody,III HS, Borgen PI, Montgomery LL: A Prospective Analysis of the Effect of Blue-Dye Volume on Sentinel Lymph Node Mapping Success and Incidence of Allergic Reaction in Patients with Breast Cancer. Annals of Surgical Oncology, 2004, 11(5):535-541.
Melanoma
Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, Maczey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G, Garbe C: Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous Melanoma. J of Investigative Dermatology, 2000, 114:637-642.
Carlson GW, Murray DR, Greenlee R, Alazraki N, Fry-Spray C, Poole R, Blais M, Hestley A, Vansant J: Management of Malignant Melanoma of the Head and Neck Using Dynamic Lymphoscinitigraphy and Gamma Probe-Guided Sentinel Lymph Node Biopsy. Arch Otolaryngol Head Neck Surg, 2000, 126:433-437.
Evans HL, Krag DN, Teates CD, Patterson JW, Meijer S, Harlow SP, Tanabe KK, Loggie BW, Whitworth PW, Kusminsky RE, Carp NZ, Gadd MA, Slingluff,Jr CL: Lymphoscintigraphy and Sentinel Node Biopsy Accurately Stage Melanoma in Patients Presenting After Wide Local Excision. Annals of Surg Oncol, 2003, 10(4):416-425.
Gietema HA, Vuylsteke RJCLM, deJonge IA, van Leeuwen PAM, Molenkamp BG, van der Sijp JRM, van Diest PJ: Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clinical Pathology, 2004, 57:618-620.
Harlow SP, Krag DN, Ashikaga T, Weaver DL, Meijer SJ, Loggie BW, Tanabe KK, Whitworth,Jr P, Kuhn J, Kusminsky R, Carp NZ, Gadd M, Rawlings,Jr M Slingluff,Jr CL: Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Research, 2001, 11:45-55.
Sentinel Node Biopsy
Clarke D, Newcombe RG, Mansel RE: The learning curve in sentinel node biopsy: the ALMANAC experience. Annals of Surgical Oncology, 2004, 11(3):211S-215S.
Rubello D, Pelizzo MR, Boni G, Schiavo R, Vaggelli L, Villa G, Sandrucci S, Piotto A, Manca G, Marini P, Mariani G: Radioguided Surgery of Primary Hyperparathyroidism Using the Low-Dose Tc99-Sestamibi Protocol: Multiinstitutional Experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS). J Nuc Med, 2005, 46:220-226.
Rubello D, Gross MK, Mariani G, Al-Nahhas A: Scintigraphic techniques in primary hyperparathyroidism: from pre-operative localization to intra-operative imaging. Eur J Nucl Med, 2007, 34:926-933.
Sidiropoulos N, Vento J, Malchoff C, Whalen G: Radioguided Tumorectomy in the Management of Parathyroid Adenomas. Archives of Surgery, 2003, 138:716-720.
OmniProbe® PET
Gulec SA, Hoenie E, Hostetter R, Schwartzentruber D: PET probe-guided surgery: applications and clinical protocol. World J of Surgical Oncology, 2007, 1-7 (page number not for citation purposes).
OmniProbe® EL
Daniel TM, Altes TA, Rehm PK, Williams MB, Jones DR, Stolin AV and Gay SB: A Novel Technique for Localization and Excisional Biopsy of Small or Ill-Defined Pulmonary Lesions. The Society of Thoracic Surgeons, 2004, 77:1756-62.
Daniel, Thomas M: A Proposed Diagnostic Approach to the Patient with the Subcentimeter Pulmonary Nodule: Techniques that Facilitate Video-Assisted Thoracic Surgery Excision. Thoracic and Cardiovascular Surgery, 2005, 17:115-122.
Gamma Probe Comparisons and Evaluations
Hoffman EJ, Tornai MP, Janecke M, Patt BE, Iwanczyk JS: Intraoperative probes and imaging probes. Eur J Nucl Med, 1999, 26:913-935.
Perkins AC and Britten A J: Specification and performance of intra-operative gamma probes for sentinel node detection. Nuclear Medicine Comm, 1999, 309-315.
Kwo DP, Barber HB, Barrett HH, Hickernell TS: Comparison of NaI(TI), CdTe, and Hgl2 surgical probes: Effect of scatter compensation on probe performance. Am Assoc Phys Med, 1991, 18(3):382-389.
Mariani G, Vaiano A, Nibale O, Rubello D: Is the "Ideal" gamma probe for intraoperative radioguided surgery conceivable? J Nuc Med, 2005, 46:388-390.
Schneebaum S, Even-Sapir E, Cohen M, Shacham-Lehrman H, Gat A, Brazovsky E, Livshitz G, Stadler J, Skornick Y: Clinical applications of gamma-detection probes - radioguided surgery. Eur J Nucl Med, 1999, 26S:S26-S35.
Wengenmair H, Kopp J: Gamma probes for Sentinel Lymph Node Localization: Quality criteria, minimal requirements and quality of commercially available systems. 2005.
Zanzonico P, Heller S: The Intraoperative Gamma Probe: Basic Principles and Choices Available. Seminars in Nuclear Medicine, 2000, 30(1):33-48.